124 related articles for article (PubMed ID: 11249637)
1. Peptide-mediated cellular delivery.
Schwartz JJ; Zhang S
Curr Opin Mol Ther; 2000 Apr; 2(2):162-7. PubMed ID: 11249637
[TBL] [Abstract][Full Text] [Related]
2. Protein transduction: an alternative to genetic intervention?
Ford KG; Souberbielle BE; Darling D; Farzaneh F
Gene Ther; 2001 Jan; 8(1):1-4. PubMed ID: 11402295
[TBL] [Abstract][Full Text] [Related]
3. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo.
Gratton JP; Yu J; Griffith JW; Babbitt RW; Scotland RS; Hickey R; Giordano FJ; Sessa WC
Nat Med; 2003 Mar; 9(3):357-62. PubMed ID: 12598894
[TBL] [Abstract][Full Text] [Related]
4. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
Gupta B; Levchenko TS; Torchilin VP
Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
[TBL] [Abstract][Full Text] [Related]
5. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
6. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria.
Fernández-Carneado J; Van Gool M; Martos V; Castel S; Prados P; de Mendoza J; Giralt E
J Am Chem Soc; 2005 Jan; 127(3):869-74. PubMed ID: 15656624
[TBL] [Abstract][Full Text] [Related]
8. The use of cell-penetrating peptides as a tool for gene regulation.
Järver P; Langel U
Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
[TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of penetration domain and killing domain peptides.
Jarajapu YP; Baltunis J; Knot HJ; Sullivan SM
J Gene Med; 2005 Jul; 7(7):908-17. PubMed ID: 15832372
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.
Snyder EL; Dowdy SF
Expert Opin Drug Deliv; 2005 Jan; 2(1):43-51. PubMed ID: 16296734
[TBL] [Abstract][Full Text] [Related]
11. Targeting the human genome.
Tachikawa K; Briggs SP
Curr Opin Biotechnol; 2006 Dec; 17(6):659-65. PubMed ID: 17085035
[TBL] [Abstract][Full Text] [Related]
12. Novel synthesis of 2'-O modified oligonucleotides by solid phase fragment condensation.
Sasaki K; Kubo T; Ueki R; Yano M; Anno Y; Ohba H; Fujii M
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1447-9. PubMed ID: 14565439
[No Abstract] [Full Text] [Related]
13. A brief introduction to cell-penetrating peptides.
Lundberg P; Langel U
J Mol Recognit; 2003; 16(5):227-33. PubMed ID: 14523933
[TBL] [Abstract][Full Text] [Related]
14. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.
Kim D; Jeon C; Kim JH; Kim MS; Yoon CH; Choi IS; Kim SH; Bae YS
Exp Cell Res; 2006 May; 312(8):1277-88. PubMed ID: 16466653
[TBL] [Abstract][Full Text] [Related]
16. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
[TBL] [Abstract][Full Text] [Related]
17. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
18. Delivery of bioactive molecules into the cell: the Trojan horse approach.
Dietz GP; Bähr M
Mol Cell Neurosci; 2004 Oct; 27(2):85-131. PubMed ID: 15485768
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
[TBL] [Abstract][Full Text] [Related]
20. Intracellular cargo delivery using tat peptide and derivatives.
Zhao M; Weissleder R
Med Res Rev; 2004 Jan; 24(1):1-12. PubMed ID: 14595670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
